In particular, high Follistatin serum levels were associated with shorter overall survival (OS) and poor prognosis in hepatocellular carcinoma29, emergence of bone metastases in prostate cancer30 or tumor proliferation of lung adenocarcinoma cells28. The gene discussed is FST; the disease is neoplasm.